Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 152–152 | Cite as

Everolimus/oxcarbazepine

Various toxicities: 12 case reports
Case report
  • 9 Downloads

Reference

  1. Saffari A, et al. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - A multicenter retrospective study. Orphanet Journal of Rare Diseases 14: 96, 3 May 2019. Available from: URL: http://doi.org/10.1186/s13023-019-1077-6 - Germany

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations